))
Double Bonus continued: An Interview with Pediatric Hematologist, Dr. Gregory Yanik PART 2
Manage episode 361438918 series 3320214
Content provided by Johnita and Lisa. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Johnita and Lisa or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
We wrap up our conversation with Dr. Gregory Yanik, Director of the Pediatric Blood and Marrow Transplant Program at the University of Michigan Medical Center in Ann Arbor, Michigan.
Parts 1 and 2 of this double bonus episode is a must-listen for every patient, family, and doctor in the healthcare field. Dr. Yanik epitomizes a model of compassion and respect for families and patients that every healthcare center should replicate and implement ASAP.
This episode covers graft versus host disease, patient advocacy, the latest in half and full-match bone marrow transplant options for patients with sickle cell anemia, gene editing, recently completed studies from the Bone Marrow Transplant Clinical Trial Network, and much more!
Chapters
1. Graft v Host disease risks (00:01:47)
2. What is Graft versus Host Disease (GVHD) (00:04:16)
3. Center Us: GVHD in black patients (00:06:13)
4. CORRECTION: GVHD is inflammation NOT rejection (00:06:20)
5. Types of GVHD (00:09:07)
6. Rejection rates: Sickle Cell Disease and Transplant (00:12:16)
7. Research studies (00:13:40)
8. Bone Marrow Transplant Clinical Trial Network (BMTCTN) (00:14:10)
9. Completing the patient care puzzle: Patient advocacy (00:18:05)
10. Adult patients with sickle cell anemia (00:22:00)
11. Gene editing (00:23:10)
12. DNA scissors (00:23:37)
13. Fetal hemoglobin (00:23:50)
14. Gene editing: Becoming part of a clinical trial (00:25:36)
15. Sickle Cell Disease Treatment Centers Act of 2022 (00:29:25)
16. Dr. Yanik's words of encouragement (00:31:20)
29 episodes
Share
